PROGRAM CHAIR
Richard J. Schwab, MD
Professor, Department of Medicine
Chief, Division of Sleep Medicine
University of Pennsylvania Perelman School of Medicine
Philadelphia, PA
PROGRAM OVERVIEW
This immersive CME experience guides learners through the evolving science and clinical management of narcolepsy. The program begins with identification of narcolepsy, reviewing essential criteria, testing, and distinguishing features that support accurate classification. The program then explores how selective loss of orexin-producing neurons disrupts sleep–wake stability, establishing orexin deficiency as the core driver of narcolepsy type 1. Finally, the program examines current guideline-supported therapies alongside emerging, mechanism-based treatments that target orexin signaling. Through interactive VR environments, clinicians gain practical, evidence-aligned strategies to optimize care for individuals living with narcolepsy.
TARGET AUDIENCE
This activity is designed to meet the educational needs of healthcare professionals involved in the treatment of patients with narcolepsy, including neurologists, sleep specialists, nurse practitioners, physician assistants, and nurses
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Summarize the role of orexin deficiency in the pathophysiology of narcolepsy.
- Describe the criteria for the diagnosis of narcolepsy.
- Evaluate current and emerging therapies and guideline recommendations for narcolepsy management
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 0.5 ANCC contact hour.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
| Faculty Member | Disclosures |
| Richard J. Schwab, MD | Consultant: Eli Lilly, Apnimed Research: CryOSA, Eli Lilly, NIH (PPG/R01 – phenotyping, genetics, state-dependent imaging), PCORI (insomnia) Medical Advisory Board: Sleep Evolution Consumer Advisory Board: Onera Royalties: UpToDate, Merck Manual |
All relevant financial relationships have been mitigated.
Content Review
The content of this activity was independently peer reviewed by a physician and nurse reviewer.
Individuals in Control of the Content of the Activity
The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:
- Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
- Dominique Barton, B.S. BSN, has nothing to disclose.
- A medical reviewer from CME Peer Review LLC, has nothing to disclose.
- Chris Drury, MA, MS, MBA, Medical Director for Med Learning Group, has nothing to disclose.
- Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
- Melissa Johnson, Program Director for Med Learning Group, has nothing to disclose.
- Millena Papastavrou, Associate Program Manager for Med Learning Group, has nothing to disclose.
- Daniel DaSilva, Accreditation and Outcomes Coordinator, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity.
In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation.
Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision making before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
RELEASED DATE: May 08, 2026
EXPIRATION DATE: May 08, 2027
Copyright © 2026 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
